255 related articles for article (PubMed ID: 29252188)
1. Serum exosomal hnRNPH1 mRNA as a novel marker for hepatocellular carcinoma.
Xu H; Dong X; Chen Y; Wang X
Clin Chem Lab Med; 2018 Feb; 56(3):479-484. PubMed ID: 29252188
[TBL] [Abstract][Full Text] [Related]
2. Serum Exosomal Long Noncoding RNAs
Xu H; Chen Y; Dong X; Wang X
Cancer Epidemiol Biomarkers Prev; 2018 Jun; 27(6):710-716. PubMed ID: 29650788
[No Abstract] [Full Text] [Related]
3. Serum exosomal microRNAs as novel biomarkers for hepatocellular carcinoma.
Sohn W; Kim J; Kang SH; Yang SR; Cho JY; Cho HC; Shim SG; Paik YH
Exp Mol Med; 2015 Sep; 47(9):e184. PubMed ID: 26380927
[TBL] [Abstract][Full Text] [Related]
4. The diagnostic value of plasma exosomal
Lyu L; Yang W; Yao J; Wang H; Zhu J; Jin A; Liu T; Wang B; Zhou J; Fan J; Yang X; Guo W
Biomark Med; 2021 Apr; 15(5):359-371. PubMed ID: 33666515
[No Abstract] [Full Text] [Related]
5. Expression characteristics and diagnostic value of annexin A2 in hepatocellular carcinoma.
Zhang HJ; Yao DF; Yao M; Huang H; Wu W; Yan MJ; Yan XD; Chen J
World J Gastroenterol; 2012 Nov; 18(41):5897-904. PubMed ID: 23139605
[TBL] [Abstract][Full Text] [Related]
6. Serum exosomal microRNAs combined with alpha-fetoprotein as diagnostic markers of hepatocellular carcinoma.
Wang Y; Zhang C; Zhang P; Guo G; Jiang T; Zhao X; Jiang J; Huang X; Tong H; Tian Y
Cancer Med; 2018 May; 7(5):1670-1679. PubMed ID: 29573235
[TBL] [Abstract][Full Text] [Related]
7. microRNA-150: a promising novel biomarker for hepatitis B virus-related hepatocellular carcinoma.
Yu F; Lu Z; Chen B; Dong P; Zheng J
Diagn Pathol; 2015 Jul; 10():129. PubMed ID: 26215970
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of exosomal microRNA-224 in development of hepatocellular carcinoma and its diagnostic and prognostic value.
Cui Y; Xu HF; Liu MY; Xu YJ; He JC; Zhou Y; Cang SD
World J Gastroenterol; 2019 Apr; 25(15):1890-1898. PubMed ID: 31057302
[TBL] [Abstract][Full Text] [Related]
9. Serum exosomal long noncoding RNA CRNDE as a prognostic biomarker for hepatocellular carcinoma.
Wang T; Zhu H; Xiao M; Zhou S
J Clin Lab Anal; 2021 Nov; 35(11):e23959. PubMed ID: 34612554
[TBL] [Abstract][Full Text] [Related]
10. Expression of serum miR-218 in hepatocellular carcinoma and its prognostic significance.
Yang L; Xu Q; Xie H; Gu G; Jiang J
Clin Transl Oncol; 2016 Aug; 18(8):841-7. PubMed ID: 26586116
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of serum exosomal miR-320d predicts poor prognosis in hepatocellular carcinoma.
Li W; Ding X; Wang S; Xu L; Yin T; Han S; Geng J; Sun W
J Clin Lab Anal; 2020 Jun; 34(6):e23239. PubMed ID: 32125733
[TBL] [Abstract][Full Text] [Related]
12. TEMs but not DKK1 could serve as complementary biomarkers for AFP in diagnosing AFP-negative hepatocellular carcinoma.
Mao L; Wang Y; Wang D; Han G; Fu S; Wang J
PLoS One; 2017; 12(9):e0183880. PubMed ID: 28902891
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic and Prognostic Roles of Serum Osteopontin and Osteopontin Promoter Polymorphisms in Hepatitis B-related Hepatocellular Carcinoma.
Chimparlee N; Chuaypen N; Khlaiphuengsin A; Pinjaroen N; Payungporn S; Poovorawan Y; Tangkijvanich P
Asian Pac J Cancer Prev; 2015; 16(16):7211-7. PubMed ID: 26514514
[TBL] [Abstract][Full Text] [Related]
14. Serum miR-96 is a promising biomarker for hepatocellular carcinoma in patients with chronic hepatitis B virus infection.
Chen Y; Dong X; Yu D; Wang X
Int J Clin Exp Med; 2015; 8(10):18462-8. PubMed ID: 26770453
[TBL] [Abstract][Full Text] [Related]
15. Protein and gene expression characteristics of heterogeneous nuclear ribonucleoprotein H1 in esophageal squamous cell carcinoma.
Sun YL; Liu F; Liu F; Zhao XH
World J Gastroenterol; 2016 Aug; 22(32):7322-31. PubMed ID: 27621578
[TBL] [Abstract][Full Text] [Related]
16. RNA sequencing of plasma exosomes revealed novel functional long noncoding RNAs in hepatocellular carcinoma.
Huang X; Sun L; Wen S; Deng D; Wan F; He X; Tian L; Liang L; Wei C; Gao K; Fu Q; Li Y; Jiang J; Zhai R; He M
Cancer Sci; 2020 Sep; 111(9):3338-3349. PubMed ID: 32506598
[TBL] [Abstract][Full Text] [Related]
17. [A preliminary study of serum marker alpha-enolase in the diagnosis of hepatocellular carcinoma].
Luo X; Wei YQ; Hai L; Hu YC; Zhao ZJ; Ma WL; Ma LN; Liu XY; Ding XC
Zhonghua Gan Zang Bing Za Zhi; 2019 Jul; 27(7):505-510. PubMed ID: 31357775
[No Abstract] [Full Text] [Related]
18. Circulating exosome-derived bona fide long non-coding RNAs predicting the occurrence and metastasis of hepatocellular carcinoma.
Lu Y; Duan Y; Xu Q; Zhang L; Chen W; Qu Z; Wu B; Liu W; Shi L; Wu D; Yang Y; Sun D; Chen X
J Cell Mol Med; 2020 Jan; 24(2):1311-1318. PubMed ID: 31811749
[TBL] [Abstract][Full Text] [Related]
19. Circulating miRNA-122, miRNA-199a, and miRNA-16 as Biomarkers for Early Detection of Hepatocellular Carcinoma in Egyptian Patients with Chronic Hepatitis C Virus Infection.
El-Abd NE; Fawzy NA; El-Sheikh SM; Soliman ME
Mol Diagn Ther; 2015 Aug; 19(4):213-20. PubMed ID: 26133725
[TBL] [Abstract][Full Text] [Related]
20. Serum miR-182 and miR-331-3p as diagnostic and prognostic markers in patients with hepatocellular carcinoma.
Chen L; Chu F; Cao Y; Shao J; Wang F
Tumour Biol; 2015 Sep; 36(10):7439-47. PubMed ID: 25903466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]